Literature DB >> 9041467

Both human alpha/beta and gamma interferons upregulate the expression of CD48 cell surface molecules.

C Tissot1, C Rebouissou, B Klein, N Mechti.   

Abstract

We have established a cDNA library from interferon (IFN)-treated human lymphoblastoid Daudi cells and made use of differential screening to search for yet unidentified IFN-regulated genes. In the course of these studies, we have isolated a human cDNA coding for the glycosyl-phosphatidylinositol-linked (GPI) membrane glycoprotein CD48 (TCT-1, Blast-1). Various studies demonstrated that the murine CD48 is the predominant counterreceptor for the mouse CD2 and is involved in the regulation of T cell activation. Since the murine CD48 is functionally homologous to the human CD2 ligand LFA-3 (CD48), the function of the human CD48 remains unknown. In this report, we show that both Hu-IFN-alpha/beta and Hu-IFN-gamma increase the level of CD48 mRNA and upregulate the expression of CD48 proteins at the surface of various cultured human cell lines. However, the IFN have no effect on the expression of LFA-3. In addition, we show that IFN increase CD48 expression on peripheral blood mononuclear CD3+, CD14+, and CD19+ subpopulations. These data suggest that in addition to modulation of the conventional MHC class I and class II-restricted interactions, the IFN might promote MHC-unrestricted interactions of target cells with the immune cells by inducing the expression of the cell surface CD48 molecule.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9041467     DOI: 10.1089/jir.1997.17.17

Source DB:  PubMed          Journal:  J Interferon Cytokine Res        ISSN: 1079-9907            Impact factor:   2.607


  6 in total

1.  CD48 is critically involved in allergic eosinophilic airway inflammation.

Authors:  Ariel Munitz; Ido Bachelet; Fred D Finkelman; Marc E Rothenberg; Francesca Levi-Schaffer
Journal:  Am J Respir Crit Care Med       Date:  2007-02-08       Impact factor: 21.405

Review 2.  Roles of CD48 in regulating immunity and tolerance.

Authors:  Shannon L McArdel; Cox Terhorst; Arlene H Sharpe
Journal:  Clin Immunol       Date:  2016-01-18       Impact factor: 3.969

Review 3.  SLAMF6 in health and disease: Implications for therapeutic targeting.

Authors:  Burcu Yigit; Ninghai Wang; Roland W Herzog; Cox Terhorst
Journal:  Clin Immunol       Date:  2018-10-23       Impact factor: 3.969

4.  Comparative Expression Analysis of Inflammatory and Immune-related Genes in Cattle During Acute Infection with Foot-and-mouth Disease Virus in Egypt.

Authors:  Abeer F El Nahas; Walaa S H Abd El Naby; Shymaa A Khatab; Al-Zahraa A Fergany; Rashed R Rashed
Journal:  J Vet Res       Date:  2021-01-26       Impact factor: 1.744

5.  Bioinformatics analysis of the clinical significance of HLA class II in breast cancer.

Authors:  Guihua Wu; Gaofang Xiao; Yuhang Yan; Chengwei Guo; Ningdong Hu; Sandi Shen
Journal:  Medicine (Baltimore)       Date:  2022-10-07       Impact factor: 1.817

6.  2B4 acts as a non-major histocompatibility complex binding inhibitory receptor on mouse natural killer cells.

Authors:  Kyung-Mi Lee; Megan E McNerney; Susan E Stepp; Porunelloor A Mathew; John D Schatzle; Michael Bennett; Vinay Kumar
Journal:  J Exp Med       Date:  2004-05-03       Impact factor: 14.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.